🔬In this episode, Dr. Shreyas Kalantri shares his journey from medical training in India to academic oncology in the United States, and reflects on what truly defines progress in cancer care.

The conversation dives deep into quality of life as a critical endpoint, disparities in immunotherapy access, the role of academic research, global oncology collaboration, and how AI can reshape oncology workflows. Dr. Kalantri also discusses his work with the HemOnc Fellows Network and ASCO’s Training & Early Career Advisory Group, highlighting the importance of mentorship and democratizing oncology education worldwide.

This episode is essential listening for oncologists, trainees, and healthcare professionals navigating the rapidly evolving oncology landscape.

🔹 Key Topics Covered

• Why quality of life should contextualize survival outcomes

• Gaps in quality-of-life reporting in clinical trials

• The HemOnc Fellows Network

• Academic oncology vs community practice

• Global oncology and trainee mentorship initiatives

• AI, digital tools, and the future of oncology workflows

• Advice for trainees considering a career in oncology

🎬A must-watch episode for oncologists, trainees, and healthcare leaders shaping the future of cancer care.

Connect with Shreyas Kalantri here: https://www.linkedin.com/in/shreyaskalantrimd/

📲 Oncology at your fingertips.

Download the ONCOassist app:

📥 iOS: https://apple.co/4iuMxfS

📥 Android: https://bit.ly/oncoassistonandroid

📥Webapp: https://bit.ly/ONCOassistOnWeb

📌 FOLLOW US FOR UPDATES: 📍 LinkedIn: https://bit.ly/oncoassistlinkedin

📍 Twitter/X: https://bit.ly/oncoassisttwitter